Hsi E - Search Results

1

Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders.

El-Salem M, Raghunath PN, Marzec M, Wlodarski P, Tsai D, Hsi E, Wasik MA. El-Salem M, et al. Among authors: hsi e. Lab Invest. 2007 Jan;87(1):29-39. doi: 10.1038/labinvest.3700494. Epub 2006 Oct 30. Lab Invest. 2007. PMID: 17075574 Free article.

2

Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative disorders.

Paessler M, Kossev P, Tsai D, Raghunath P, Majewski M, Zhang Q, Ramalingam P, Schuster S, Tomaszewski J, Arber DA, Hsi E, Wasik MA. Paessler M, et al. Among authors: hsi e. Lab Invest. 2002 Nov;82(11):1599-606. doi: 10.1097/01.lab.0000036873.16297.a5. Lab Invest. 2002. PMID: 12429820 Free article.

3

The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders.

Tsao L, Hsi ED. Tsao L, et al. Arch Pathol Lab Med. 2007 Aug;131(8):1209-18. doi: 10.5858/2007-131-1209-TCSOPL. Arch Pathol Lab Med. 2007. PMID: 17683183 Free article. Review.

4

Mammalian target of rapamycin (mTOR) regulates cellular proliferation and tumor growth in urothelial carcinoma.

Hansel DE, Platt E, Orloff M, Harwalker J, Sethu S, Hicks JL, De Marzo A, Steinle RE, Hsi ED, Theodorescu D, Ching CB, Eng C. Hansel DE, et al. Among authors: hsi ed. Am J Pathol. 2010 Jun;176(6):3062-72. doi: 10.2353/ajpath.2010.090872. Epub 2010 Apr 15. Am J Pathol. 2010. PMID: 20395440 Free PMC article.

5

Rapid determination of cell-associated tumor necrosis factor production by flow cytometry.

Hsi ED, Remick DG. Hsi ED, et al. Lab Invest. 1993 Jun;68(6):740-5. Lab Invest. 1993. PMID: 8515659

6

Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature.

Hsi ED, Picken MM, Alkan S. Hsi ED, et al. Mod Pathol. 1998 May;11(5):479-84. Mod Pathol. 1998. PMID: 9619602 Review.

7

Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.

Raible MD, Hsi ED, Alkan S. Raible MD, et al. Among authors: hsi ed. Am J Clin Pathol. 1999 Jul;112(1):101-7. doi: 10.1093/ajcp/112.1.101. Am J Clin Pathol. 1999. PMID: 10396291

8

Cutaneous presentation of posttransplant lymphoproliferative disorder.

Schumann KW, Oriba HA, Bergfeld WF, Hsi ED, Hollandsworth K. Schumann KW, et al. Among authors: hsi ed. J Am Acad Dermatol. 2000 May;42(5 Pt 2):923-6. doi: 10.1016/s0190-9622(00)90273-1. J Am Acad Dermatol. 2000. PMID: 10767706

9

Detection of T-cell receptor-gamma gene rearrangement in lymphoproliferative disorders by temperature gradient gel electrophoresis.

Alkan S, Cosar E, Ergin M, Hsi E. Alkan S, et al. Among authors: hsi e. Arch Pathol Lab Med. 2001 Feb;125(2):202-7. doi: 10.5858/2001-125-0202-DOTCRG. Arch Pathol Lab Med. 2001. PMID: 11175635 Free article.

10

Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience.

Ramalingam P, Rybicki L, Smith MD, Abrahams NA, Tubbs RR, Pettay J, Farver CF, Hsi ED. Ramalingam P, et al. Among authors: hsi ed. Mod Pathol. 2002 Jun;15(6):647-56. doi: 10.1038/modpathol.3880581. Mod Pathol. 2002. PMID: 12065779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters